...
机译:远程缺血预处理抑制血小板αIIBIIBβ33在冠状动脉疾病患者接受双抗血小板治疗的激活:随机试验
Department of CardiologyUniversity of SydneyConcord NSW Australia;
ANZAC Research InstituteUniversity of SydneyConcord NSW Australia;
ANZAC Research InstituteUniversity of SydneyConcord NSW Australia;
ANZAC Research InstituteUniversity of SydneyConcord NSW Australia;
ANZAC Research InstituteUniversity of SydneyConcord NSW Australia;
ANZAC Research InstituteUniversity of SydneyConcord NSW Australia;
ACRF Department of Cancer Biology and TherapeuticsAustralian National UniversityCanberra ACT;
Department of CardiologyUniversity of SydneyConcord NSW Australia;
ANZAC Research InstituteUniversity of SydneyConcord NSW Australia;
Department of CardiologyUniversity of SydneyConcord NSW Australia;
coronary artery disease; ischemic preconditioning; platelet activation; platelet antagonists; platelet glycoprotein GPIIb‐IIIa complex;
机译:远程缺血预处理抑制血小板αIIBIIBβ33在冠状动脉疾病患者接受双抗血小板治疗的激活:随机试验
机译:阿托伐他汀对冠状动脉疾病患者血小板反应性患者的药效学作用 - 双抗血小板治疗 - 珍珠随机交叉研究
机译:阿托伐他汀与瑞舒伐他汀在血小板反应正常的同时接受双重抗血小板治疗的冠心病患者的药效学作用-PEARL随机交叉研究
机译:缺血性卒中患者的血小板活化和抗血小板治疗
机译:急性冠状动脉疾病中的血小板活化,血小板-中性粒细胞相互作用及其对抗血栓形成剂的调节
机译:日本冠状动脉支架植入术患者的双重抗血小板治疗后高血小板反应性与缺血事件之间的关系
机译:远程缺血预处理抑制血小板αSIIBβ3接受双抗血小板治疗的冠状动脉疾病患者中的激活:随机试验